GENB Financials

Income Statement
MetricQ2 2026Q1 2026
Revenue
6.3M
-12.6%
7.2M
Cost of Revenue
0
0
Gross Profit
6.3M
-12.6%
7.2M
Operating Expenses
77.9M
+9.2%
71.3M
R&D
64.3M
+11.3%
57.8M
SG&A
13.6M
+0.5%
13.5M
Operating Income
-71614000
-11.7%
-64112000
EBITDA
-68390000
-12.4%
-60839000
Net Income
-67255000
-9.0%
-61714000
EPS (Basic)
$-0.52
+51.4%
$-1.07
EPS (Diluted)
$-0.52
+51.4%
$-1.07
Shares (Diluted)
128.2M
+97.7%
64.9M
Generate Biomedicines (GENB) โ€” Financials